The study shows that liver X receptors, which are regulators of cholesterol, fat and inflammatory gene expression, also control the fibrosis-making cells of the liver, known as hepatic stellate cells. In chronic liver injury (due to excess fat, for example), stellate cells become activated and launch an inflammatory and fibrotic cascade that can eventually result in liver fibrosis. Liver X receptors, when stimulated, “turn on” several hundred genes that have been shown to suppress these inflammatory processes.
The researchers noted in an experiment involving mice that after replicating chronic liver injury, mice without liver X receptors had dramatically more liver fibrosis than normal mice.
Read the news release about liver X receptors.
Read other coverage about GI studies:
– Letter, Phone Call Improves CRC Screening Adherence, Especially Among Minorities
– Nonadvanced Adenoma Patients Can Extend Colorectal Cancer Surveillance Beyond 5 Years
– EUS-Guided Fine-Needle Biopsy Device Yields 85% Diagnostic Accuracy
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
